Since both hypoxia and GCs are involved in angiogenesis and influence the macrophage function e.g. by inducing GILZ expression, it is possible that the hypoxic tumour environment in combination with GC treatment also causes the upregulation of GILZ expression and thereby preventing overactivation of immune cells. This evidence concerns the gene TSC22D3 and neoplasm.